7
May
2024

Polpharma Group
Exhibitor at CPHI North America 2024 stand 814
About Us
Categories

-
PL
-
2015On CPHI since
-
3Certificates
-
5000+Employees
Company types
Event information
CPHI North America 2024
-
07 May 2024 - 09 May 2024
-
Pennsylvania Convention Center, Philadelphia
-
Visit us at stand 814
Products Featured at CPHI North America 2024
-
Product Ticagrelor
DISCLAIMER
The above product is presented solely for informational purposes and does not constitute an offer in any sense. Products with PIPELINE & EARLY DEVELOPMENT STATUS under patent (SPC) protection in Poland and/or other countries are not offered until expiration of the corresponding IP... -
Product Baclofen
Therapeutical Area: Musculo-skeletal system • EU DMF available • US DMF no. 18014 available • Japanese DMF available • CEP available
Indication: Baclofen is primarily used for the treatment of spastic movement disorders and alcoholism.
-
Product Risedronate sodium
Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 20384 available • Japanese DMF available • CEP available
Indication: Risedronate sodium is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism.
-
Product Hydrochlorothiazide
Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 17599 available • Japanese DMF available • CEP available
Indication: Hydrochlorothiazide is a diuretic drug of the thiazide class that acts by inhibiting the kidneys' ability to retain water. This reduces the volum... -
Product Tadalafil
Therapeutic area: genito-urinary system & sex hormones
EU DMF available
US DMF : 24590
CEP available
-
Product Alendronate sodium
Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 16962 available • Japanese DMF available • CEP available
Indication: Alendronate sodium is a bisphosphonate drug used for osteoporosis and several other bone diseasesMusculo-skeletal diseases
-
Product Acenocoumarol
Therapeutic Area: Cardiovascular systemEU DMF available Indication: Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist -
Product Acetazolamide
Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 10383 available • CEP available Available also in injectable form
Indication: Acetazolamide decreases the pressure in the eye and is used for adjunctive treatment of glaucoma, a condition in which increased pressure ... -
Product Aripiprazole
Therapeutic Area: Nervous System • EU DMF available • US DMF no. 23314 available • CEP available
Indication: used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). It is also used together with other medications to treat major depr... -
Product Carbamazepine
Therapeutic Area: Nervous System
• EU DMF available • US DMF no. 26266 available • CEP available Indication: Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia.
-
Product Carvedilol
Therapeutic Area: Cardiovascular system • EU DMF available • US DMF no. 17060 available • CEP available
Indication: Carvedilol is a carbazole derivative acts as anti-hypertensive agent. It is formulated as tablets for oral route of administration. Carvedilol is indicated for the management of e... -
Product Clopamide
Therapeutic Area: Cardiovascular system • EU DMF available
Indication: Clopamide is indicated for the treatment of oedema, hypertension. It is formulated as tablet for oral administration. It is categorised as a thiazide like drug and works in similar way as the thiazide diuretics. It acts at the p... -
Product Carvedilol phosphate hemihydrate
Therapeutic area: Cardiovascular system • EU DMF available • US DMF no. 20633 available -
Product Etodolac
Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 11405 available • Japanese DMF available • CEP available
Indication: Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, fever, and inflammation.
-
Product Ibandronate Sodium
Therapeutic Area: Musculo-skeletal system • EU DMF available • US DMF no. 25638 available • Chinese DMF - under registration
Indication: Ibradronic Sodium is a potent bisphosphonate drug used in the prevention and treatment of osteoporosis
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance